These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3956057)

  • 1. Salsalate kinetics in patients with chronic renal failure undergoing hemodialysis.
    Williams ME; Weinblatt M; Rosa RM; Griffin VL; Goldlust MB; Shang SF; Harrison LI; Brown RS
    Clin Pharmacol Ther; 1986 Apr; 39(4):420-4. PubMed ID: 3956057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefprozil in healthy subjects and patients with renal impairment.
    Shyu WC; Pittman KA; Wilber RB; Matzke GR; Barbhaiya RH
    J Clin Pharmacol; 1991 Apr; 31(4):362-71. PubMed ID: 2037710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of cefpodoxime proxetil in hemodialysis patients.
    Borin MT; Hughes GS; Kelloway JS; Shapiro BE; Halstenson CE
    J Clin Pharmacol; 1992 Nov; 32(11):1038-44. PubMed ID: 1474165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefepime in subjects with renal insufficiency.
    Barbhaiya RH; Knupp CA; Forgue ST; Matzke GR; Guay DR; Pittman KA
    Clin Pharmacol Ther; 1990 Sep; 48(3):268-76. PubMed ID: 2401125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ceftazidime in patients with renal insufficiency and in those undergoing hemodialysis.
    Ohkawa M; Nakashima T; Shoda R; Ikeda A; Orito M; Sawaki M; Sugata T; Shimamura M; Hirano S; Okumura K
    Chemotherapy; 1985; 31(6):410-6. PubMed ID: 3908006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of hemodialysis on piperacillin pharmacokinetics.
    Heim-Duthoy KL; Halstenson CE; Abraham PA; Matzke GR
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):680-4. PubMed ID: 3818147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and nondialyzability of mexiletine in renal failure.
    Wang T; Wuellner D; Woosley RL; Stone WJ
    Clin Pharmacol Ther; 1985 Jun; 37(6):649-53. PubMed ID: 4006364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefamandole in patients undergoing hemodialysis and peritoneal dialysis.
    Ahern MJ; Finkelstein FO; Andriole VT
    Antimicrob Agents Chemother; 1976 Sep; 10(3):457-61. PubMed ID: 984787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of theophylline in peritoneal dialysis and hemodialysis.
    Lee CS; Peterson JC; Marbury TC
    J Clin Pharmacol; 1983 Jul; 23(7):274-80. PubMed ID: 6886029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function.
    Horadam VW; Sharp JG; Smilack JD; McAnalley BH; Garriott JC; Stephens MK; Prati RC; Brater DC
    Ann Intern Med; 1981 Apr; 94(4 pt 1):454-8. PubMed ID: 7212501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption, biotransformation, and pharmacokinetics of salicylsalicylic acid in humans.
    Harrison LI; Funk ML; Ré ON; Ober RE
    J Clin Pharmacol; 1981 Oct; 21(10):401-4. PubMed ID: 7309902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metronidazole kinetics in dialysis patients.
    Kreeft JH; Ogilvie RI; Dufresne LR
    Surgery; 1983 Jan; 93(1 Pt 2):149-53. PubMed ID: 6849199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic study of an oral cephalosporin, cefdinir, in hemodialysis patients.
    Hishida A; Ohishi K; Nagashima S; Kanamaru M; Obara M; Kitada A
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1718-21. PubMed ID: 9661010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of moxalactam in anuric children and during hemodialysis.
    Kaplan SL; Berry PL; Mason EO; Kramer WG
    Pediatr Pharmacol (New York); 1983; 3(1):29-36. PubMed ID: 6646877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of ranitidine after intravenous administration in hemodialysis patients.
    Garg DC; Baltodano N; Perez GO; Oster JR; Jallad NS; Weidler DJ
    Pharmacology; 1985; 31(4):189-93. PubMed ID: 4059323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of aminoguanidine in end-stage renal disease patients on hemodialysis.
    Foote EF; Look ZM; Giles P; Keane WF; Halstenson CE
    Am J Kidney Dis; 1995 Mar; 25(3):420-5. PubMed ID: 7872319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
    Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of tinidazole in chronic renal failure and in patients on haemodialysis.
    Flouvat BL; Imbert C; Dubois DM; Temperville BP; Roux AF; Chevalier GC; Humbert G
    Br J Clin Pharmacol; 1983 Jun; 15(6):735-41. PubMed ID: 6871072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posaconazole pharmacokinetics, safety, and tolerability in subjects with varying degrees of chronic renal disease.
    Courtney R; Sansone A; Smith W; Marbury T; Statkevich P; Martinho M; Laughlin M; Swan S
    J Clin Pharmacol; 2005 Feb; 45(2):185-92. PubMed ID: 15647411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.